SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-19-010967
Filing Date
2019-01-17
Accepted
2019-01-17 07:37:33
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d632967dsc14d9.htm SC 14D9 567390
2 EX-(E)(9) d632967dex99e9.htm EX-99.(E)(9) 52598
3 EX-(E)(10) d632967dex99e10.htm EX-99.(E)(10) 50616
4 EX-(E)(11) d632967dex99e11.htm EX-99.(E)(11) 50623
  Complete submission text file 0001193125-19-010967.txt   722767
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filed by) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Subject) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-88267 | Film No.: 19530072
SIC: 2834 Pharmaceutical Preparations